Financial Review: Stevanato Group (STVN) & Its Peers

Stevanato Group (NYSE:STVN) is one of 109 public companies in the “Life Sciences Tools & Services” industry, but how does it weigh in compared to its rivals? We will compare Stevanato Group to related businesses based on the strength of its institutional ownership, analyst recommendations, risk, dividends, valuation, profitability and earnings.

Institutional & Insider Ownership

54.3% of shares of all “Life Sciences Tools & Services” companies are held by institutional investors. 15.2% of shares of all “Life Sciences Tools & Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Volatility & Risk

Stevanato Group has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Stevanato Group’s rivals have a beta of 0.94, suggesting that their average stock price is 6% less volatile than the S&P 500.

Profitability

This table compares Stevanato Group and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.24%	10.51%	6.22%
Stevanato Group Competitors	-539.78%	77.25%	-13.56%

Valuation and Earnings

This table compares Stevanato Group and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Stevanato Group	$1.34 billion	$158.21 million	23.76
Stevanato Group Competitors	$2.28 billion	$55.88 billion	-7.63

Stevanato Group’s rivals have higher revenue and earnings than Stevanato Group. Stevanato Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Stevanato Group and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0	5	2	2	2.67
Stevanato Group Competitors	957	3183	5516	178	2.50

As a group, “Life Sciences Tools & Services” companies have a potential downside of 2.74%. Given Stevanato Group’s rivals higher possible upside, analysts plainly believe Stevanato Group has less favorable growth aspects than its rivals.

Summary

Stevanato Group rivals beat Stevanato Group on 8 of the 13 factors compared.

Stevanato Group Company Profile

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.